Healthcare
Thailand to become the medicine hub of Southeast Asia
Japanese drugmakers are interested in establishing their main manufacturing sites in Thailand.
Thailand to become the medicine hub of Southeast Asia
Japanese drugmakers are interested in establishing their main manufacturing sites in Thailand.
India medicine sales to increase 9.4% by 2029
Telemedicine service is expected to prevail in the coming years.
Sri Lanka pharma market to grow 1.6% by 2024
Local firms will benefit from the government support to improve capacity and supply.
Chinese pharma market to grow 3.2% this year
The Government’s efforts to cut drug spending will create challenges for international drugmakers.
HSBC releases China pharma market outlook for H2
Small cap companies with low valuations could outperform, but leading companies may provide more stable returns.
Biofourmis closes Series C funding, reels in $100m
The round was led by SoftBank Vision Fund 2, and the company plans to use the funding to accelerate global expansion.
Fujitsu, Tokyo Shinagawa to develop AI-supported diagnosis of COVID-19 pneumonia
The system is expected to deliver early detection of cases, even when the probablity of infection is low.
Lumiere32 rolls out AI-powered inventory management software
The company is offering free 6-months trials for all clinics in Singapore.
Sino Biopharma records $1,852m revenue in H1
Earnings per share were 5.2% higher than that of the same period last year.
IHH Healthcare acquires Prince Court Medical Centre in Kuala Lumpur
It became the 16th hospital under the group in Malaysia.
Lee's Pharma announces H1 results
The group’s revenue is up 3.9% measured QoQ.
Thomson Medical to roll out secure messaging platform
The end-to-end encryption system is expected to protect patient data privacy.
Bumrungrad International Hospital creates first digital microbiology laboratories.
This includes the digitization of its core laboratory, handling 60-70% of its annual tests.
COVID-19 dampens Japan's pharma market
Reduced healthcare spending will affect multinationals' capabilities to launch new products.
Malaysia's ageing population to drive healthcare demand
The country is having high incidence and prevalence of non-communicable diseases.
COVID-19 pushes healthcare sector reform in Pakistan
Poor track record may delay the process despite the government's political will.
Australia healthcare spending signals future growth
High demand is forecasted in the pharmaceuticals industry.